Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.

Chen AB, Punglia RS, Kuntz KM, Mauch PM, Ng AK.

J Clin Oncol. 2009 Nov 10;27(32):5383-9. doi: 10.1200/JCO.2009.22.8460. Epub 2009 Sep 14.

2.

Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis.

Das P, Ng AK, Earle CC, Mauch PM, Kuntz KM.

Ann Oncol. 2006 May;17(5):785-93. Epub 2006 Feb 24.

PMID:
16500905
3.

Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.

Wattson DA, Hunink MG, DiPiro PJ, Das P, Hodgson DC, Mauch PM, Ng AK.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):344-53. doi: 10.1016/j.ijrobp.2014.06.013. Epub 2014 Aug 4.

PMID:
25104066
4.

Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.

Guadagnolo BA, Punglia RS, Kuntz KM, Mauch PM, Ng AK.

J Clin Oncol. 2006 Sep 1;24(25):4116-22.

PMID:
16943528
6.

The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.

Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM.

JAMA. 1999 May 19;281(19):1822-9.

PMID:
10340370
7.

Visual screening for malignant melanoma: a cost-effectiveness analysis.

Losina E, Walensky RP, Geller A, Beddingfield FC 3rd, Wolf LL, Gilchrest BA, Freedberg KA.

Arch Dermatol. 2007 Jan;143(1):21-8.

8.

Cost-Effectiveness of interferon alfa-2b added to chemotherapy for high-tumor-burden follicular non-Hodgkin's lymphoma.

Wirt DP, Giles FJ, Oken MM, Solal-Celigny P, Beck JR.

Leuk Lymphoma. 2001 Feb;40(5-6):565-79.

PMID:
11426529
9.
10.

Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.

Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.

Lung Cancer. 2005 May;48(2):171-85. Epub 2005 Jan 4.

PMID:
15829317
11.

What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea?

Park SM, Kim SY, Earle CC, Jeong SY, Yun YH.

World J Gastroenterol. 2009 Jul 7;15(25):3153-60.

12.

Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.

Wong FL, Bhatia S, Landier W, Francisco L, Leisenring W, Hudson MM, Armstrong GT, Mertens A, Stovall M, Robison LL, Lyman GH, Lipshultz SE, Armenian SH.

Ann Intern Med. 2014 May 20;160(10):672-83. doi: 10.7326/M13-2498.

13.

Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany.

Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Siebert U.

GMS Health Technol Assess. 2010 Apr 27;6:Doc05. doi: 10.3205/hta000083.

14.

Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women.

Nayak S, Roberts MS, Greenspan SL.

Ann Intern Med. 2011 Dec 6;155(11):751-61. doi: 10.7326/0003-4819-155-11-201112060-00007.

15.

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.

Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.

16.

Cost effectiveness of mammography screening for Chinese women.

Wong IO, Kuntz KM, Cowling BJ, Lam CL, Leung GM.

Cancer. 2007 Aug 15;110(4):885-95. Erratum in: Cancer. 2010 Jan 15;116(2):540.

17.

An economic evaluation of an abdominal aortic aneurysm screening program in Italy.

Giardina S, Pane B, Spinella G, Cafueri G, Corbo M, Brasseur P, Orengo G, Palombo D.

J Vasc Surg. 2011 Oct;54(4):938-46. doi: 10.1016/j.jvs.2011.03.264. Epub 2011 Aug 6.

18.
19.

Cost-effectiveness of screening for colorectal cancer in the general population.

Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

JAMA. 2000 Oct 18;284(15):1954-61.

PMID:
11035892
20.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

Supplemental Content

Support Center